文献速递乳腺MR

合成MRI在乳腺癌患者中的可行性:与多回波自旋回波T2映射法的T2弛豫时间比较

The feasibility of synthetic MRI in breast cancer patients: comparison of T2 relaxation time with multiecho spin echo T2 mapping method.
PubMed 文献 · Br J Radiol · 2018-09-21

2017年1月至5月纳入51例新诊断乳腺癌患者,比较合成MRI与多回波自旋回波T2映射法测量的T2弛豫时间。癌灶平均T2弛豫时间合成MRI为84.75 ms、MESE为90.35 ms,脂肪分别为129.22 ms和102.11 ms;两种方法在癌灶和脂肪均呈显著正相关。雌激素受体阳性和低组织学分级与两种方法间较小差异相关。

要点

  • 合成MRI与MESE T2映射法测量的乳腺癌T2弛豫时间呈显著正相关(r=0.713,p<0.001)。
  • 脂肪组织两种方法差异较大,平均差异27.8 ms,相关性较低(r=0.551)。
  • 雌激素受体阳性(p=0.02)和低组织学分级(p=0.043)与两种方法间较小差异相关。

核心结论

  • 合成MRI测量的乳腺癌T2弛豫时间与MESE T2映射法呈正相关,合成MRI可能有助于通过同时采集多个定量物理特性来评估组织特征。

研究设计与样本

  • 2017年1月至2017年5月纳入51例新诊断乳腺癌患者,均额外行合成MRI和多回波自旋回波(MESE)T2映射序列;由一名具有9年乳腺影像经验的放射科医生在连续两个包含肿瘤中心层面的轴位图像上沿肿瘤边缘手动勾画感兴趣区,并在对侧乳腺脂肪组织勾画感兴趣区。

关键影像表现/征象

  • 癌灶平均T2弛豫时间合成MRI为84.75 ms(±15.54),MESE T2映射为90.35 ms(±19.22)。
  • 脂肪平均T2弛豫时间合成MRI为129.22 ms(±9.53),MESE T2映射为102.11 ms(±13.9)。

诊断标准与关键数值

  • Bland-Altman分析显示乳腺癌平均差异为8.4 ms,脂肪组织平均差异较大为27.8 ms。
  • Spearman相关检验显示合成MRI与MESE序列在癌灶(r=0.713,p<0.001)和脂肪(r=0.551,p<0.001)均呈显著正相关。
  • 雌激素受体阳性和低组织学分级与两种方法间较小差异相关(p=0.02和p=0.043)。

临床应用与阅片要点

  • 合成MRI可同时获取T1、T2弛豫时间和质子密度图,可能用于评估乳腺组织特征。
  • 在乳腺癌T2弛豫时间测量上,合成MRI与MESE T2映射法结果呈正相关,但脂肪组织差异较大。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To compare the T2 relaxation times acquired with synthetic MRI to those of multi-echo spin-echo sequences and to evaluate the usefulness of synthetic MRI in the clinical setting.

METHODS: From January 2017 to May 2017, we included 51 patients with newly diagnosed breast cancer, who underwent additional synthetic MRI and multiecho spin echo (MESE) T2 mapping sequences. Synthetic MRI technique uses a multiecho and multidelay acquisition method for the simultaneous quantification of physical properties such as T1 and T2 relaxation times and proton density image map. A radiologist with 9 years of experience in breast imaging drew region of interests manually along the tumor margins on two consecutive axial sections including the center of tumor mass and in the fat tissue of contralateral breast on both synthetic T2 map and MESE T2 map images.

RESULTS: The mean T2 relaxation time of the cancer was 84.75 ms (± 15.54) by synthetic MRI and 90.35 ms (± 19.22) by MESE T2 mapping. The mean T2 relaxation time of the fat was 129.22 ms (± 9.53) and 102.11 ms (± 13.9), respectively. Bland-Altman analysis showed mean difference of 8.4 ms for the breast cancer and a larger mean difference of 27.8 ms for the fat tissue. Spearman's correlation test showed that there was significant positive correlation between synthetic MRI and MESE sequences for the cancer (r = 0.713, p < 0.001) and for the fat (r = 0.551, p < 0.001). The positive estrogen receptor and low histologic grade were associated with little differences between two methods (p = 0.02 and = 0.043, respectively).

CONCLUSION: T2 relaxation times of breast cancer acquired with synthetic MRI showed positive correlation with those of MESE T2 mapping. Synthetic MRI could be useful for the evaluation of tissue characteristics by simultaneous acquisition of several quantitative physical properties.

ADVANCES IN KNOWLEDGE: Synthetic MRI is useful for the evaluation of T2 relaxation times of the breast cancers.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Jung Y, Gho SM, Back SN, et al. The feasibility of synthetic MRI in breast cancer patients: comparison of T2 relaxation time with multiecho spin echo T2 mapping method. Br J Radiol. 2018. PMID: 30215550. doi:10.1259/bjr.20180479

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。